This company has been acquired
Ocean Bio-Chem Management
Management criteria checks 4/4
Key information
Peter Dornau
Chief executive officer
US$356.6k
Total compensation
| CEO salary percentage | 62.4% |
| CEO tenure | 49.6yrs |
| CEO ownership | 2.8% |
| Management average tenure | 16.9yrs |
| Board average tenure | 15yrs |
Recent management updates
This Insider Has Just Sold Shares In Ocean Bio-Chem, Inc. (NASDAQ:OBCI)
Jan 01
Ocean Bio-Chem, Inc. (NASDAQ:OBCI) Insiders Have Been Selling
Dec 15A Quick Analysis On Ocean Bio-Chem's (NASDAQ:OBCI) CEO Salary
Nov 21Recent updates
Here's Why Ocean Bio-Chem (NASDAQ:OBCI) Can Manage Its Debt Responsibly
Jun 23Capital Investments At Ocean Bio-Chem (NASDAQ:OBCI) Point To A Promising Future
Apr 07Ocean Bio-Chem (NASDAQ:OBCI) Might Become A Compounding Machine
Dec 16Ocean Bio-Chem's (NASDAQ:OBCI) Dividend Will Be US$0.03
Nov 26Ocean Bio-Chem's (NASDAQ:OBCI) Shareholders Have More To Worry About Than Only Soft Earnings
Nov 22These 4 Measures Indicate That Ocean Bio-Chem (NASDAQ:OBCI) Is Using Debt Safely
Nov 03Ocean Bio-Chem (NASDAQ:OBCI) Will Pay A Dividend Of US$0.03
Sep 02With EPS Growth And More, Ocean Bio-Chem (NASDAQ:OBCI) Is Interesting
Aug 17Ocean Bio-Chem And Its Real Value
Aug 05Is Ocean Bio-Chem (NASDAQ:OBCI) A Risky Investment?
Jul 27Estimating The Intrinsic Value Of Ocean Bio-Chem, Inc. (NASDAQ:OBCI)
May 29Investors Should Be Encouraged By Ocean Bio-Chem's (NASDAQ:OBCI) Returns On Capital
May 17Ocean Bio-Chem (NASDAQ:OBCI) Seems To Use Debt Rather Sparingly
Mar 17Be Sure To Check Out Ocean Bio-Chem, Inc. (NASDAQ:OBCI) Before It Goes Ex-Dividend
Mar 05Why Ocean Bio-Chem, Inc. (NASDAQ:OBCI) Is A Dividend Rockstar
Feb 22Why We Like The Returns At Ocean Bio-Chem (NASDAQ:OBCI)
Feb 09Is Weakness In Ocean Bio-Chem, Inc. (NASDAQ:OBCI) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?
Jan 27Do Ocean Bio-Chem's (NASDAQ:OBCI) Earnings Warrant Your Attention?
Jan 14
This Insider Has Just Sold Shares In Ocean Bio-Chem, Inc. (NASDAQ:OBCI)
Jan 01Shareholders of Ocean Bio-Chem (NASDAQ:OBCI) Must Be Delighted With Their 610% Total Return
Dec 28Ocean Bio-Chem, Inc. (NASDAQ:OBCI) Insiders Have Been Selling
Dec 15Is Ocean Bio-Chem (NASDAQ:OBCI) Using Too Much Debt?
Dec 03Ocean Bio-Chem goes ex-dividend tomorrow
Dec 01Ocean Bio-Chem authorizes $3M share repurchase program
Nov 23A Quick Analysis On Ocean Bio-Chem's (NASDAQ:OBCI) CEO Salary
Nov 21Ocean Bio-Chem Has Maintained Momentum, But Not Enough For New Highs
Nov 19CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2022 | n/a | n/a | US$5m |
| Mar 31 2022 | n/a | n/a | US$8m |
| Dec 31 2021 | US$357k | US$222k | US$8m |
| Sep 30 2021 | n/a | n/a | US$9m |
| Jun 30 2021 | n/a | n/a | US$10m |
| Mar 31 2021 | n/a | n/a | US$11m |
| Dec 31 2020 | US$319k | US$208k | US$10m |
| Sep 30 2020 | n/a | n/a | US$9m |
| Jun 30 2020 | n/a | n/a | US$6m |
| Mar 31 2020 | n/a | n/a | US$3m |
| Dec 31 2019 | US$294k | US$200k | US$3m |
| Sep 30 2019 | n/a | n/a | US$3m |
| Jun 30 2019 | n/a | n/a | US$3m |
| Mar 31 2019 | n/a | n/a | US$3m |
| Dec 31 2018 | US$312k | US$195k | US$3m |
| Sep 30 2018 | n/a | n/a | US$3m |
| Jun 30 2018 | n/a | n/a | US$3m |
| Mar 31 2018 | n/a | n/a | US$3m |
| Dec 31 2017 | US$300k | US$183k | US$3m |
| Sep 30 2017 | n/a | n/a | US$3m |
| Jun 30 2017 | n/a | n/a | US$3m |
| Mar 31 2017 | n/a | n/a | US$3m |
| Dec 31 2016 | US$260k | US$171k | US$2m |
| Sep 30 2016 | n/a | n/a | US$2m |
| Jun 30 2016 | n/a | n/a | US$479k |
| Mar 31 2016 | n/a | n/a | -US$64k |
| Dec 31 2015 | US$210k | US$161k | US$461k |
Compensation vs Market: Peter's total compensation ($USD356.57K) is below average for companies of similar size in the US market ($USD770.24K).
Compensation vs Earnings: Peter's compensation has been consistent with company performance over the past year.
CEO
Peter Dornau (82 yo)
49.6yrs
Tenure
US$356,571
Compensation
Mr. Peter G. Dornau co-founded Ocean Bio-Chem Inc. and has been its Chief Executive Officer, President, Chairman and Director since 1973.
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 49.6yrs | US$356.57k | 2.79% $ 3.5m | |
| CFO, VP of Finance & Director | 15.4yrs | US$302.48k | 1.89% $ 2.3m | |
| COO, VP | 18.3yrs | US$305.11k | 2.7% $ 3.3m | |
| Executive VP of Sales & Marketing and Director | 15yrs | US$388.43k | 4.8% $ 6.0m | |
| Controller of Financial Reporting | no data | no data | no data |
16.9yrs
Average Tenure
65.5yo
Average Age
Experienced Management: OBCI's management team is seasoned and experienced (16.9 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 49.6yrs | US$356.57k | 2.79% $ 3.5m | |
| CFO, VP of Finance & Director | 15yrs | US$302.48k | 1.89% $ 2.3m | |
| COO, VP | 15yrs | US$305.11k | 2.7% $ 3.3m | |
| Executive VP of Sales & Marketing and Director | 15yrs | US$388.43k | 4.8% $ 6.0m | |
| Director | 24.3yrs | US$14.95k | 0.76% $ 941.6k | |
| Independent Director | 22.2yrs | US$17.75k | 0.84% $ 1.0m | |
| Independent Director | 11.3yrs | US$17.75k | 0.063% $ 77.8k | |
| Independent Director | 6.1yrs | US$17.75k | 0.053% $ 65.2k |
15.0yrs
Average Tenure
64yo
Average Age
Experienced Board: OBCI's board of directors are seasoned and experienced ( 15 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2022/08/09 13:20 |
| End of Day Share Price | 2022/08/08 00:00 |
| Earnings | 2022/06/30 |
| Annual Earnings | 2021/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Ocean Bio-Chem, Inc. is covered by 0 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|